Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
The New Jersey-based arm of the drug firm is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets, as per the latest Enforcement Report of the US health regulator.
The affected lot has been manufactured at the Goa plant of the Mumbai-based drug firm and then supplied to Glenmark Pharmaceuticals Inc, USA, the USFDA said.
The firm is recalling the affected bottles due to it being "Subpotent", it noted.
Glenmark Pharmaceuticals Inc initiated the nationwide (US) Class III recall on August 14 this year, it added.
As per the USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Food Giants Selling Less Healthy Products In Low-And-Middle-Income Countries: Report
Cipla, Glenmark Recall Asthma Drugs Made In Indore From US Market Glenmark Pharma To Sell 75% Stake In Life Sciences To Nirma For $680 Million Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market Amazon Employee Greets Friend At Wedding, Dies Of Cardiac Arrest "Violation Of Sovereignty, Abuse Of Power": Kanwal Sibal On US Report On Adani Group "Truth Is...": BJP Leader Slaps Case Against Rahul Gandhi In Cash-For-Vote Row Ather 450, Rizta Electric Scooters Now Get 8-Year Battery Warranty Dear ICC, Wake Up: Hybrid Model Is Must For India If Pak Has Hosting Rights Notre-Dame In Paris Set To Reopen Next Month, Elon Musk Shares Video Track Latest News Live on NDTV.com and get news updates from India and around the world.